Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Director | March 18, 2021 | March 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CASTLE BIOSCIENCES INC
Report date March 18, 2021 · Filed March 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 124,407 |
Reported balance
After 2021-03-18 transaction · row 1
1 source rowRow 1 · 2021-03-18 · Exercise / conversion · Acquired 12,229 · Balance 124,407 |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2029-07-23 | Direct | 18,666 |
Reported balance
After 2021-03-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-03-18 · Exercise / conversion · Disposed 12,229 · Balance 18,666 F4: 25% of the 30,895 shares originally subject to the option vested on August 1, 2020, and the remaining shares vest in 36 equal monthly installments thereafter. |
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 628,410 |
Reported balance
Holding disclosure · report date 2021-03-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 628,410 F1: Held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"), MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F2: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. |
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 717 |
Reported balance
Holding disclosure · report date 2021-03-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 717 F3: Held by MOD Partners, LLC ("MOD LLC"). The Reporting Person is the President and a member of MOD LLC and has voting and investment power over the shares held by MOD LLC. The Reporting Person disclaims beneficial ownership of the shares held by MOD LLC as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. |
Filing footnotes · ownership attribution and instrument terms
F1: Held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"), MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP.
F2: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F3: Held by MOD Partners, LLC ("MOD LLC"). The Reporting Person is the President and a member of MOD LLC and has voting and investment power over the shares held by MOD LLC. The Reporting Person disclaims beneficial ownership of the shares held by MOD LLC as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F4: 25% of the 30,895 shares originally subject to the option vested on August 1, 2020, and the remaining shares vest in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionSeries E-2 Preferred Stock · Derivative | 5,461 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · derivative · entry 12 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,479 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.exercise_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.expiration_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionSeries E-1 Preferred Stock · Derivative | 463,453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · derivative · entry 11 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 380,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.exercise_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.expiration_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F3 · ownership.nature: Held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"). MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP") is the general partner of MGC 2013 LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP"), and shares voting and investment power over the shares held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP") and MGC Venture Partners QP 2018, L.P. ("MGC QP 2018 LP"). The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC QP 2018 LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionSeries D Preferred Stock · Derivative | 337,754 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · derivative · entry 10 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 277,074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.exercise_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.expiration_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F3 · ownership.nature: Held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"). MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP") is the general partner of MGC 2013 LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP"), and shares voting and investment power over the shares held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP") and MGC Venture Partners QP 2018, L.P. ("MGC QP 2018 LP"). The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC QP 2018 LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionSeries D Preferred Stock · Derivative | 15,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · derivative · entry 9 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,058 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.exercise_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.expiration_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionSeries B Preferred Stock · Derivative | 122,158 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · derivative · entry 8 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,210 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.exercise_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.expiration_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionSeries A Preferred Stock · Derivative | 19,524 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · derivative · entry 7 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 16,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.exercise_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · derivative.expiration_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F3 · ownership.nature: Held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"). MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP") is the general partner of MGC 2013 LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP"), and shares voting and investment power over the shares held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP") and MGC Venture Partners QP 2018, L.P. ("MGC QP 2018 LP"). The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC QP 2018 LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | PurchaseCommon Stock | 22,245 | $16.00 | $355,920.00 |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · nonDerivative · entry 6 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,053 F6 · shares: Represents a purchase from the underwriters in the Issuer's IPO. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionCommon Stock | 16,722 | $12.80 | $214,041.60 |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · nonDerivative · entry 5 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $205,970.51. Upon closing of the IPO, the Conversion Amount automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 80% of the IPO price per share of $16.00 per share. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionCommon Stock | 169,086 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · nonDerivative · entry 4 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares of Common Stock issued upon conversion of the Preferred Stock were calculated by first aggregating all series of Preferred Stock held by the Reporting Person, in accordance with the terms of the Company's then-effective Certificate of Incorporation. F2 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | PurchaseCommon Stock | 312,500 | $16.00 | $5,000,000.00 |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · nonDerivative · entry 3 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,746,855 F6 · shares: Represents a purchase from the underwriters in the Issuer's IPO. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP"), and shares voting and investment power over the shares held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP") and MGC Venture Partners QP 2018, L.P. ("MGC QP 2018 LP"). The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC QP 2018 LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes. F7 · ownership.nature: Held by MGC 2013 LP, MGC 2018 LP and MGC QP 2018 LP. MGC 2018 GP is the general partner of MGC 2018 LP and MGC QP 2018 LP. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionCommon Stock | 97,428 | $12.80 | $1,247,078.40 |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · nonDerivative · entry 2 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,434,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,200,000.00. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the "Conversion Amount") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 80% of the IPO price per share of $16.00 per share. F3 · ownership.nature: Held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"). MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP") is the general partner of MGC 2013 LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP"), and shares voting and investment power over the shares held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP") and MGC Venture Partners QP 2018, L.P. ("MGC QP 2018 LP"). The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC QP 2018 LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:38 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionCommon Stock | 1,336,927 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043886 · doc4.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,336,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares of Common Stock issued upon conversion of the Preferred Stock were calculated by first aggregating all series of Preferred Stock held by the Reporting Person, in accordance with the terms of the Company's then-effective Certificate of Incorporation. F2 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F3 · ownership.nature: Held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"). MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP") is the general partner of MGC 2013 LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP"), and shares voting and investment power over the shares held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP") and MGC Venture Partners QP 2018, L.P. ("MGC QP 2018 LP"). The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC QP 2018 LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.